We have identified, and we believe for the first time, specific non-conventional imaging differences between multiple sclerosis and AQP4 antibody NMOSD, which correspond to their distinct pathology in the cerebral white matter, and in the future can be tested as diagnostic discriminators in separate cohorts. Here, AQP4 is linked to multiple sclerosis.